Green tea extract is effective in treating chronic leukemia
Researchers have discovered in a new study that green tea extract may be effective in treating chronic lymphocytic leukemia.
Researchers at the Center for Myoclinic Medicine in the United States have found that using a chemical called epigallocatechin gallate, abbreviated EGCG, which is the main ingredient in green tea, can reduce the number of leukemia cells in patients. .
The results of laboratory studies in the first phase of clinical trials on this compound have been promising.
Although definitive results on the effects of EGCG will be known by the end of the third phase of the trials, so far the surprisingly positive effects of this compound in most patients with leukemia, said Dr. Tate Shanaflett, a hematologist at the Myoclinic Center who co-authored the study. Observed and can be useful to reduce the growth of the disease.
The scientists stressed that EGCG should not be considered as a chemotherapeutic agent, according to the Myoclinic Medical Center website.
According to the report, chronic lymphocytic leukemia, or CLL, is a very slow-growing cancer associated with hematopoietic organs in the elderly, which is more common in men over 50 years of age. This disease is often accidentally detected during a routine blood test for other diseases.
According to experts, common symptoms in the early stages of the disease that occur gradually include fatigue and general weakness, mild to moderate anemia, enlarged and stiff lymph nodes, weight loss without common causes, tenderness, and enlargement of the spleen. Sometimes accompanied by skin knots.
But in the advanced stages and late diagnosis, these symptoms include inability to fight bacterial, viral, or fungal infections and debilitating weakness. The causes of the disease are unknown.
Diagnostic tests show lymphocyte proliferation, a type of white blood cell. Unlike some types of leukemia, excessive exposure to radiation does not appear to be the underlying cause of chronic lymphocytic leukemia.